ID   DOSC_ECOLI              Reviewed;         460 AA.
AC   P0AA89; P77793;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 1.
DT   15-FEB-2017, entry version 97.
DE   RecName: Full=Diguanylate cyclase DosC;
DE            Short=DGC;
DE            EC=2.7.7.65;
DE   AltName: Full=Direct oxygen-sensing cyclase;
GN   Name=dosC; Synonyms=yddV; OrderedLocusNames=b1490, JW5241;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M.,
RA   Makino K., Miki T., Mizobuchi K., Mori H., Mori T., Motomura K.,
RA   Nakade S., Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N.,
RA   Sampei G., Seki Y., Sivasundaram S., Tagami H., Takeda J.,
RA   Takemoto K., Takeuchi Y., Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   FUNCTION AS A DIGUANYLATE CYCLASE, AND OPERON STRUCTURE.
RC   STRAIN=K12 / MG1655 / ATCC 47076, K12 / W3110 / ATCC 27325 / DSM 5911,
RC   and TOB1;
RX   PubMed=16418169; DOI=10.1074/jbc.M510701200;
RA   Mendez-Ortiz M.M., Hyodo M., Hayakawa Y., Membrillo-Hernandez J.;
RT   "Genome-wide transcriptional profile of Escherichia coli in response
RT   to high levels of the second messenger 3',5'-cyclic diguanylic acid.";
RL   J. Biol. Chem. 281:8090-8099(2006).
RN   [5]
RP   RPOS-DEPENDENCE.
RC   STRAIN=K12 / MC4100;
RX   PubMed=17010156; DOI=10.1111/j.1365-2958.2006.05440.x;
RA   Weber H., Pesavento C., Possling A., Tischendorf G., Hengge R.;
RT   "Cyclic-di-GMP-mediated signalling within the sigma network of
RT   Escherichia coli.";
RL   Mol. Microbiol. 62:1014-1034(2006).
RN   [6]
RP   CATALYTIC ACTIVITY, HEME COFACTOR, O(2)-BINDING, INTERACTION WITH
RP   DOSP, AND OPERON STRUCTURE.
RX   PubMed=19764732; DOI=10.1021/bi901409g;
RA   Tuckerman J.R., Gonzalez G., Sousa E.H., Wan X., Saito J.A., Alam M.,
RA   Gilles-Gonzalez M.A.;
RT   "An oxygen-sensing diguanylate cyclase and phosphodiesterase couple
RT   for c-di-GMP control.";
RL   Biochemistry 48:9764-9774(2009).
RN   [7]
RP   INDUCTION, AND RPOS-DEPENDENCE.
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=19332833; DOI=10.1099/mic.0.024257-0;
RA   Sommerfeldt N., Possling A., Becker G., Pesavento C., Tschowri N.,
RA   Hengge R.;
RT   "Gene expression patterns and differential input into curli fimbriae
RT   regulation of all GGDEF/EAL domain proteins in Escherichia coli.";
RL   Microbiology 155:1318-1331(2009).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, ENZYME REGULATION, DOMAIN, O(2)-BINDING,
RP   CO-BINDING, CYANIDE-BINDING, IMIDAZOLE-BINDING, KINETIC PARAMETERS,
RP   REDOX POTENTIAL, MUTAGENESIS OF TYR-43; GLN-60; HIS-98; HIS-223;
RP   ARG-365; ASP-368; ASP-376 AND GLU-377, ABSORPTION SPECTROSCOPY, AND
RP   RESONANCE RAMAN SPECTROSCOPY.
RC   STRAIN=K12;
RX   PubMed=21067162; DOI=10.1021/bi100733q;
RA   Kitanishi K., Kobayashi K., Kawamura Y., Ishigami I., Ogura T.,
RA   Nakajima K., Igarashi J., Tanaka A., Shimizu T.;
RT   "Important roles of Tyr43 at the putative heme distal side in the
RT   oxygen recognition and stability of the Fe(II)-O2 complex of YddV, a
RT   globin-coupled heme-based oxygen sensor diguanylate cyclase.";
RL   Biochemistry 49:10381-10393(2010).
RN   [9]
RP   ROLE IN MOTILITY, AND DISRUPTION PHENOTYPE.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=20303158; DOI=10.1016/j.cell.2010.01.018;
RA   Boehm A., Kaiser M., Li H., Spangler C., Kasper C.A., Ackermann M.,
RA   Kaever V., Sourjik V., Roth V., Jenal U.;
RT   "Second messenger-mediated adjustment of bacterial swimming
RT   velocity.";
RL   Cell 141:107-116(2010).
RN   [10]
RP   FUNCTION IN REGULATION OF CSGBAC EXPRESSION, DISRUPTION PHENOTYPE, AND
RP   INDUCTION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=20553324; DOI=10.1111/j.1574-695X.2010.00702.x;
RA   Tagliabue L., Maciag A., Antoniani D., Landini P.;
RT   "The yddV-dos operon controls biofilm formation through the regulation
RT   of genes encoding curli fibers' subunits in aerobically growing
RT   Escherichia coli.";
RL   FEMS Immunol. Med. Microbiol. 59:477-484(2010).
RN   [11]
RP   FUNCTION IN REGULATION OF PGAABCD EXPRESSION, DISRUPTION PHENOTYPE,
RP   AND MUTAGENESIS OF 376-ASP-GLU-377.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=20576684; DOI=10.1099/mic.0.041350-0;
RA   Tagliabue L., Antoniani D., Maciag A., Bocci P., Raffaelli N.,
RA   Landini P.;
RT   "The diguanylate cyclase YddV controls production of the
RT   exopolysaccharide poly-N-acetylglucosamine (PNAG) through regulation
RT   of the PNAG biosynthetic pgaABCD operon.";
RL   Microbiology 156:2901-2911(2010).
RN   [12]
RP   MUTAGENESIS OF LEU-65, AND ABSORPTION SPECTROSCOPY.
RC   STRAIN=K12;
RX   PubMed=22005448; DOI=10.1016/j.jinorgbio.2011.09.019;
RA   Nakajima K., Kitanishi K., Kobayashi K., Kobayashi N., Igarashi J.,
RA   Shimizu T.;
RT   "Leu65 in the heme distal side is critical for the stability of the
RT   Fe(II)-O(2) complex of YddV, a globin-coupled oxygen sensor
RT   diguanylate cyclase.";
RL   J. Inorg. Biochem. 108:163-170(2012).
CC   -!- FUNCTION: Globin-coupled heme-based oxygen sensor protein
CC       displaying diguanylate cyclase (DGC) activity in response to
CC       oxygen availability. Thus, catalyzes the synthesis of cyclic
CC       diguanylate (c-di-GMP) via the condensation of 2 GTP molecules. Is
CC       involved in the modulation of intracellular c-di-GMP levels, in
CC       association with DosP which catalyzes the degradation of c-di-GMP
CC       (PDE activity). Cyclic-di-GMP is a second messenger which controls
CC       cell surface-associated traits in bacteria. DosC regulates biofilm
CC       formation through the oxygen-dependent activation of the csgBAC
CC       operon, which encodes curli structural subunits, while not
CC       affecting the expression of the regulatory operon csgDEFG. DosC,
CC       but not the other DGCs in E.coli, also promotes the production of
CC       the exopolysaccharide poly-N-acetylglucosamine (PNAG) through up-
CC       regulation of the expression of the PNAG biosynthetic pgaABCD
CC       operon, independently of CsrA.
CC   -!- FUNCTION: Overexpression leads to an increased level of c-di-GMP,
CC       which leads to changes in the cell surface, to abnormal cell
CC       division, increased biofilm formation and decreased swimming (the
CC       latter 2 in strain W3110). In a strain able to produce cellulose
CC       (strain TOB1, a fecal isolate) overexpression leads to an increase
CC       in cellulose production.
CC   -!- CATALYTIC ACTIVITY: 2 GTP = 2 diphosphate + cyclic di-3',5'-
CC       guanylate. {ECO:0000269|PubMed:19764732,
CC       ECO:0000269|PubMed:21067162}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC       Note=Binds 1 heme group per subunit. The Fe(2+) state binds O(2)
CC       and CO while the Fe(3+) state can bind CN(-) and imidazole.;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250};
CC   -!- ENZYME REGULATION: Activity depends on O(2)-binding and heme redox
CC       state: the Fe(III), Fe(II)-O(2), and Fe(II)-CO complexes of DosC
CC       are active forms, whereas Fe(II) and Fe(II)-NO complexes are
CC       inactive forms. {ECO:0000269|PubMed:21067162}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Note=The Fe(III), Fe(II)-O(2), and Fe(II)-CO complexes of DosC
CC         display DGC activity with turnover numbers of 0.066, 0.022, and
CC         0.022 min(-1), respectively. The DGC reaction catalyzed by DosC
CC         is the rate-determining step for c-di-GMP homeostasis. Binds
CC         O(2), CO, cyanide and imidazole with a dissociation constant of
CC         14 uM, 0.095 uM, 4.7 uM and 0.055 uM, respectively.
CC         {ECO:0000269|PubMed:21067162};
CC       Redox potential:
CC         E(0) is -17 mV.;
CC   -!- PATHWAY: Purine metabolism; 3',5'-cyclic di-GMP biosynthesis.
CC   -!- SUBUNIT: Forms a complex with DosP.
CC   -!- INDUCTION: By RpoS in the late exponential growth phase and upon
CC       entry into stationary phase. Expression is higher at 28 than 37
CC       degrees Celsius. In rich medium DosC and YdaM are the major RpoS-
CC       dependent GGDEF-domain containing proteins in the cell, whereas in
CC       minimal medium it is the major RpoS-dependent GGDEF-domain
CC       containing protein. Highly expressed on solid medium. A member of
CC       the dosCP operon. {ECO:0000269|PubMed:19332833,
CC       ECO:0000269|PubMed:20553324}.
CC   -!- DOMAIN: Is composed of an N-terminal sensory globin-fold domain
CC       that binds heme and oxygen, and a C-terminal GGDEF diguanylate
CC       cyclase domain. {ECO:0000269|PubMed:21067162}.
CC   -!- DISRUPTION PHENOTYPE: Disruption results in a 2.5-fold reduction
CC       in surface adhesion, a 3.5-fold reduction in biofilm formation, a
CC       large reduction in curli production, a drastic decrease in csgB
CC       expression (400-fold reduction in aerobic growth) and in an
CC       approximately 3.5-fold reduction in pgaA transcript levels in
CC       comparison with wild-type. Disruption partially suppresses the
CC       reduced motility of a yhjH disruption; concomitant disruption of
CC       dosC, yegE, yedQ and yfiN completely restores motility, suggesting
CC       these 4 genes, together with the c-di-GMP phosphodiesterase YhjH,
CC       form a network that regulates cell motility by altering levels of
CC       c-di-GMP. {ECO:0000269|PubMed:20303158,
CC       ECO:0000269|PubMed:20553324, ECO:0000269|PubMed:20576684}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA15155.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U00096; AAC74563.3; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15155.2; ALT_INIT; Genomic_DNA.
DR   PIR; E64902; E64902.
DR   RefSeq; NP_416007.3; NC_000913.3.
DR   RefSeq; WP_000426292.1; NZ_LN832404.1.
DR   PDB; 4ZVA; X-ray; 2.00 A; A/B=8-170.
DR   PDB; 4ZVB; X-ray; 2.40 A; A/B/C/D=1-155.
DR   PDB; 4ZVC; X-ray; 1.50 A; A/B=173-298.
DR   PDB; 4ZVD; X-ray; 1.90 A; A/B=173-298.
DR   PDB; 4ZVE; X-ray; 1.20 A; A=297-460.
DR   PDB; 4ZVF; X-ray; 1.15 A; A=297-460.
DR   PDB; 4ZVG; X-ray; 2.20 A; A/B=297-460.
DR   PDB; 4ZVH; X-ray; 3.30 A; A/B=297-460.
DR   PDBsum; 4ZVA; -.
DR   PDBsum; 4ZVB; -.
DR   PDBsum; 4ZVC; -.
DR   PDBsum; 4ZVD; -.
DR   PDBsum; 4ZVE; -.
DR   PDBsum; 4ZVF; -.
DR   PDBsum; 4ZVG; -.
DR   PDBsum; 4ZVH; -.
DR   ProteinModelPortal; P0AA89; -.
DR   SMR; P0AA89; -.
DR   BioGrid; 4262162; 6.
DR   STRING; 511145.b1490; -.
DR   EPD; P0AA89; -.
DR   PaxDb; P0AA89; -.
DR   PRIDE; P0AA89; -.
DR   DNASU; 945835; -.
DR   EnsemblBacteria; AAC74563; AAC74563; b1490.
DR   EnsemblBacteria; BAA15155; BAA15155; BAA15155.
DR   GeneID; 945835; -.
DR   KEGG; ecj:JW5241; -.
DR   KEGG; eco:b1490; -.
DR   PATRIC; 32118274; VBIEscCol129921_1557.
DR   EchoBASE; EB3554; -.
DR   EcoGene; EG13793; dosC.
DR   eggNOG; ENOG4105BZU; Bacteria.
DR   eggNOG; ENOG410XNMH; LUCA.
DR   HOGENOM; HOG000006777; -.
DR   InParanoid; P0AA89; -.
DR   KO; K13069; -.
DR   OMA; DGHPDYE; -.
DR   BioCyc; EcoCyc:G6784-MONOMER; -.
DR   BioCyc; MetaCyc:G6784-MONOMER; -.
DR   BRENDA; 2.7.7.65; 2026.
DR   UniPathway; UPA00599; -.
DR   PRO; PR:P0AA89; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0052621; F:diguanylate cyclase activity; IDA:EcoCyc.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0020037; F:heme binding; IDA:EcoCyc.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019825; F:oxygen binding; IDA:EcoCyc.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   CDD; cd01949; GGDEF; 1.
DR   Gene3D; 1.10.490.10; -; 1.
DR   InterPro; IPR000160; GGDEF_dom.
DR   InterPro; IPR009050; Globin-like.
DR   InterPro; IPR012292; Globin/Proto.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   Pfam; PF00990; GGDEF; 1.
DR   SMART; SM00267; GGDEF; 1.
DR   SUPFAM; SSF46458; SSF46458; 1.
DR   SUPFAM; SSF55073; SSF55073; 1.
DR   TIGRFAMs; TIGR00254; GGDEF; 1.
DR   PROSITE; PS50887; GGDEF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; GTP-binding; Heme; Iron; Magnesium;
KW   Metal-binding; Nucleotide-binding; Reference proteome; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN         1    460       Diguanylate cyclase DosC.
FT                                /FTId=PRO_0000201321.
FT   DOMAIN      325    458       GGDEF. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00095}.
FT   ACT_SITE    376    376       Proton acceptor. {ECO:0000255}.
FT   METAL        98     98       Iron (heme proximal ligand).
FT   METAL       333    333       Magnesium. {ECO:0000250}.
FT   METAL       376    376       Magnesium. {ECO:0000250}.
FT   BINDING     341    341       Substrate. {ECO:0000250}.
FT   BINDING     350    350       Substrate. {ECO:0000250}.
FT   SITE         43     43       Involved in oxygen binding and important
FT                                for the stability of the Fe(II)-O(2)
FT                                complex.
FT   SITE         60     60       Important for oxygen binding and
FT                                stability of the Fe(II)-O(2) complex.
FT   SITE         65     65       Critical for restricting water access to
FT                                the heme distal side to avoid rapid
FT                                autoxidation.
FT   SITE        338    338       Transition state stabilizer.
FT                                {ECO:0000255}.
FT   MUTAGEN      43     43       Y->A,L: Same biofilm formation activity
FT                                as wild-type. Large decrease in O(2)
FT                                affinity. {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN      43     43       Y->F,W: Same biofilm formation activity
FT                                as wild-type. Markedly enhanced O(2)
FT                                dissociation but not association rate
FT                                constants. Highly enhanced autoxidation
FT                                rate constant.
FT                                {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN      60     60       Q->A,E: Same biofilm formation activity
FT                                as wild-type. Enhanced O(2) dissociation
FT                                but not association rate constants.
FT                                Enhanced autoxidation rate constant.
FT                                {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN      60     60       Q->L: Same biofilm formation activity as
FT                                wild-type. 5-fold reduction in O(2)
FT                                dissociation rate constant. Significant
FT                                decrease in the autoxidation rate
FT                                constant. {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN      65     65       L->G,T: Enhanced autoxidation rate
FT                                constant. Markedly enhanced O(2)
FT                                association rate constant.
FT                                {ECO:0000269|PubMed:22005448}.
FT   MUTAGEN      65     65       L->M,Q: Enhanced autoxidation rate
FT                                constant. Decrease in O(2) association
FT                                rate constant.
FT                                {ECO:0000269|PubMed:22005448}.
FT   MUTAGEN      98     98       H->A: Same biofilm formation activity as
FT                                wild-type. Loss of heme-binding ability.
FT                                {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN     223    223       H->A: Same biofilm formation activity as
FT                                wild-type. {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN     365    365       R->A: Same biofilm formation activity as
FT                                wild-type. {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN     368    368       D->A: Lacks biofilm formation activity,
FT                                and thus is probably devoid of
FT                                diguanylate cyclase activity.
FT                                {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN     376    377       DE->AA: Loss of DGC activity. Stimulation
FT                                of PNAG production and activation of
FT                                pgaABCD expression are abolished.
FT                                {ECO:0000269|PubMed:20576684}.
FT   MUTAGEN     376    376       D->A: Lacks biofilm formation activity,
FT                                and thus is probably devoid of
FT                                diguanylate cyclase activity.
FT                                {ECO:0000269|PubMed:21067162}.
FT   MUTAGEN     377    377       E->A: Lacks biofilm formation activity,
FT                                and thus is probably devoid of
FT                                diguanylate cyclase activity.
FT                                {ECO:0000269|PubMed:21067162}.
FT   HELIX         8     18       {ECO:0000244|PDB:4ZVA}.
FT   HELIX        21     48       {ECO:0000244|PDB:4ZVA}.
FT   HELIX        50     53       {ECO:0000244|PDB:4ZVA}.
FT   HELIX        59     77       {ECO:0000244|PDB:4ZVA}.
FT   HELIX        81     83       {ECO:0000244|PDB:4ZVA}.
FT   HELIX        84    101       {ECO:0000244|PDB:4ZVA}.
FT   HELIX       105    124       {ECO:0000244|PDB:4ZVA}.
FT   STRAND      126    128       {ECO:0000244|PDB:4ZVA}.
FT   HELIX       130    152       {ECO:0000244|PDB:4ZVA}.
FT   HELIX       178    203       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       212    214       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       216    223       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       225    228       {ECO:0000244|PDB:4ZVC}.
FT   TURN        229    231       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       233    254       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       256    260       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       262    291       {ECO:0000244|PDB:4ZVC}.
FT   HELIX       299    302       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      303    305       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       306    308       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       309    323       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      327    334       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       337    344       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       346    363       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      368    374       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      377    384       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       387    402       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      409    411       {ECO:0000244|PDB:4ZVH}.
FT   STRAND      418    424       {ECO:0000244|PDB:4ZVF}.
FT   HELIX       431    447       {ECO:0000244|PDB:4ZVF}.
FT   STRAND      453    455       {ECO:0000244|PDB:4ZVF}.
SQ   SEQUENCE   460 AA;  53178 MW;  79168311553E61C3 CRC64;
     MEMYFKRMKD EWTGLVEQAD PPIRAKAAEI AVAHAHYLSI EFYRIVRIDP HAEEFLSNEQ
     VERQLKSAME RWIINVLSAQ VDDVERLIQI QHTVAEVHAR IGIPVEIVEM GFRVLKKILY
     PVIFSSDYSA AEKLQVYHFS INSIDIAMEV MTRAFTFSDS SASKEDENYR IFSLLENAEE
     EKERQIASIL SWEIDIIYKI LLDSDLGSSL PLSQADFGLW FNHKGRHYFS GIAEVGHISR
     LIQDFDGIFN QTMRNTRNLN NRSLRVKFLL QIRNTVSQII TLLRELFEEV SRHEVGMDVL
     TKLLNRRFLP TIFKREIAHA NRTGTPLSVL IIDVDKFKEI NDTWGHNTGD EILRKVSQAF
     YDNVRSSDYV FRYGGDEFII VLTEASENET LRTAERIRSR VEKTKLKAAN GEDIALSLSI
     GAAMFNGHPD YERLIQIADE ALYIAKRRGR NRVELWKASL
//
